Vibegron
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB14895 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 10 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | polycystic kidney disease 3 with or without polycystic liver disease | KG + DL |
| 2 | mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies | KG + DL |
| 3 | renal-hepatic-pancreatic dysplasia | KG + DL |
| 4 | Joubert syndrome with renal defect | KG + DL |
| 5 | thoracic malformation | KG + DL |
| 6 | esophageal varices with bleeding | KG + DL |
| 7 | esophageal varices without bleeding | KG + DL |
| 8 | karyomegalic interstitial nephritis | KG + DL |
| 9 | adult familial nephronophthisis-spastic quadriparesia syndrome | KG + DL |
| 10 | hypotrichosis simplex of the scalp | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.